Novo Nordisk shares rise after dropping Metsera bid

Shares in Novo Nordisk NOVOb.CO rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its bid for U.S.

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...
FOX 11 Los Angeles

Dr. Oz jumps in as drug exec collapses during Oval Office press conference

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...

Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits

NEW YORK/LONDON (Reuters) -U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping ...

Novo Nordisk: Hold On Tightly As The Market Tests Your Faith

Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.

Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Real Winner.

Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Real Winner.
PolitiFact

Novo Nordisk's Gordon Findlay didn't faint Nov. 6, 2025, in the Oval Office. He wasn't even there

Gordon Findlay is a Novo Nordisk manager based in Switzerland who didn’t attend the White House’s Nov. 6 drug pricing announcement. Robert F. Kennedy Jr. wasn’t fleeing the scene, a White House ...

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera.

Why Novo Nordisk Stock Is Sinking This Week

The stock price for Danish drugmaker Novo Nordisk ( NVO 2.06%) is down more than 8% since last Friday's close. What's going ...